Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.

Abstract:

:Mucin 1 (MUC1), a bound mucin glycoprotein, is overexpressed and aberrantly glycosylated in >80% of human ductal pancreatic carcinoma. Evidence suggests that MUC1 can be used as a tumor marker and is a potential target for immunotherapy of pancreatic cancer. However, vaccination with MUC1 peptides fails to stimulate the immune response against cancer cells because immunity toward tumor-associated antigens (TAA), including MUC1, in cancer patients is relatively weak, and the presentation of these TAAs to the immune system is poor due to their low immunogenicity. We investigated whether vaccination with immunogenetically enhanced MUC1 (by expressing alpha-gal epitopes; Galalpha1-3Galbeta1-4GlcNAc-R) can elicit effective antibody production for MUC1 itself as well as certain TAAs derived from pancreatic cancer cells and induced tumor-specific T-cell responses. We also used alpha1,3galactosyltransferase (alpha1,3GT) knockout mice that were preimmunized with pig kidney and transplanted with B16F10 melanoma cells transfected with MUC1 expression vector. Vaccination of these mice with alpha-gal MUC1 resulted in marked inhibition of tumor growth and significant improvement of overall survival time compared with mice vaccinated with MUC1 alone (P = 0.003). Furthermore, vaccination with pancreatic cancer cells expressing alpha-gal epitopes induced immune responses against not only differentiated cancer cells but also cancer stem cells. The results suggested that vaccination using cells engineered to express alpha-gal epitopes is a novel strategy for treatment of pancreatic cancer.

journal_name

Cancer Res

journal_title

Cancer research

authors

Deguchi T,Tanemura M,Miyoshi E,Nagano H,Machida T,Ohmura Y,Kobayashi S,Marubashi S,Eguchi H,Takeda Y,Ito T,Mori M,Doki Y,Sawa Y

doi

10.1158/0008-5472.CAN-09-4313

subject

Has Abstract

pub_date

2010-07-01 00:00:00

pages

5259-69

issue

13

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-09-4313

journal_volume

70

pub_type

杂志文章
  • DNA-protein cross-linking and DNA interstrand cross-linking by haloethylnitrosoureas in L1210 cells.

    abstract::Bifunctional alkylating agents are known to produce cross-links between DNA and protein and between paired DNA strands. The possibility of discriminating these two classes of cross-links in L1210 cells treated with haloethylnitrosoureas or nitrogen mustard was explored with the alkaline elution technique. Two classes ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ewig RA,Kohn KW

    更新日期:1978-10-01 00:00:00

  • DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA.

    abstract::The linear chromosomes of vertebrates terminate in telomeres that consist of a tandemly repeated hexameric sequence, 5'TTAGGG3'. Telomeres form a protective loop structure (t-loop), which is thought to prevent them from being recognized as a double-strand break. Approximately 10% of human tumors prevent shortening of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-1556

    authors: Fasching CL,Neumann AA,Muntoni A,Yeager TR,Reddel RR

    更新日期:2007-08-01 00:00:00

  • Reactivity of fecapentaene-12 toward thiols, DNA, and these constituents in human fibroblasts.

    abstract::Micromolar concentrations of fecapentaene-12, a mutagen found in human feces, decrease survival measured as colony-forming efficiency and membrane integrity of cultured human fibroblasts. Fecapentaene-12 also decreases the content of cellular free low-molecular-weight thiols including glutathione. Fecapentaene-12 reac...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dypbukt JM,Edman CC,Sundqvist K,Kakefuda T,Plummer SM,Harris CC,Grafström RC

    更新日期:1989-11-01 00:00:00

  • Cellular changes and antitumor responses in the plasmacytoma-bearing mouse following cyclophosphamide treatment.

    abstract::Mice bearing the immunosuppressive plasmacytoma TEPC-183 exhibit a marked splenic hyperplasia. We have characterized these tumor-reactive splenocytes on the basis of cell surface marker expression, nonspecific esterase activity, and morphology. Although splenocyte numbers increased progressively throughout tumor growt...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shanahan TC,Ceglowski WS,Havas HF

    更新日期:1985-12-01 00:00:00

  • Pharmacokinetics of 111In-labeled anti-p97 monoclonal antibody in patients with metastatic malignant melanoma.

    abstract::Twenty-eight patients with metastatic malignant melanoma received anti-p97 murine monoclonal antibody (96.5) infused over 2 h at doses between 1 and 20 mg coupled to either 2.5 or 5.0 mCi of 111In by the bifunctional chelating agent diethyltriaminepentaacetic acid. Clearance of 111In from plasma closely fit an open, o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rosenblum MG,Murray JL,Haynie TP,Glenn HJ,Jahns MF,Benjamin RS,Frincke JM,Carlo DJ,Hersh EM

    更新日期:1985-05-01 00:00:00

  • Assessment of immune responses to tumors using cryostat sections of bronchogenic carcinoma.

    abstract::Thirty patients with lung cancer were studied using the leukocyte migration-inhibition assay. Cryostat sections of autologous and homologous carcinoma tissues and normal lung were used as antigens. Although no inhibition of migration was seen using autologous cancer tissues, seven of 30 patients (23%) demonstrated inh...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Erickson AD

    更新日期:1980-10-01 00:00:00

  • An analysis of monoclonal antibody distribution in microscopic tumor nodules: consequences of a "binding site barrier".

    abstract::Rational in vivo application of monoclonal antibodies for diagnosis and therapy of cancer requires an understanding of both the global and microscopic pharmacology of macromolecular ligands. Here, we introduce a new mathematical model for antibody distribution into small, prevascular, densely packed nodules (represent...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: van Osdol W,Fujimori K,Weinstein JN

    更新日期:1991-09-15 00:00:00

  • Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest.

    abstract::Loss of susceptibility to apoptosis signals is a crucial step in carcinogenesis. Therefore, sensitization of tumor cells to apoptosis is a promising therapeutic strategy. c-Jun-N-terminal-kinases (JNK) have been implicated in stress-induced apoptosis, but may also contribute to survival signaling. Here we show that CD...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-2618

    authors: Kuntzen C,Sonuc N,De Toni EN,Opelz C,Mucha SR,Gerbes AL,Eichhorst ST

    更新日期:2005-08-01 00:00:00

  • Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells.

    abstract::Increased expression of cyclooxygenase (COX) and overproduction of prostaglandins (PGs) have been implicated in the development and progression of colorectal cancer (CRC). Nonsteroidal anti-inflammatory agents (NSAIDS) inhibit growth of various CRC cell lines by both COX-dependent and COX-independent pathways. To spec...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chinery R,Coffey RJ,Graves-Deal R,Kirkland SC,Sanchez SC,Zackert WE,Oates JA,Morrow JD

    更新日期:1999-06-01 00:00:00

  • Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment.

    abstract::As with many types of cancer, cell motility is an important factor in the progression and metastasis of hepatocellular carcinomas (HCC). HCC is associated with significant fibrosis in the liver. The fibrotic microenvironment in the liver is characterized by an altered composition of the extracellular matrix (ECM) and ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yang C,Zeisberg M,Lively JC,Nyberg P,Afdhal N,Kalluri R

    更新日期:2003-12-01 00:00:00

  • Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong.

    abstract::One hundred seven Chinese patients with primary hepatocellular carcinoma (PHC) were compared with 107 hospital controls for the presence of hepatitis B surface antigen and smoking, drinking, and dietary habits. Eighty-two % of PHC cases were hepatitis B surface antigen positive compared to 18% of controls (relative ri...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lam KC,Yu MC,Leung JW,Henderson BE

    更新日期:1982-12-01 00:00:00

  • Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.

    abstract::Patients with disseminated Ewing's family of tumors (ESFT) often experience drug-resistant relapse. We hypothesize that targeting minimal residual disease with the cytotoxic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR; fenretinide) may decrease relapse. We determined the following: (a) 4-HPR cytotoxicity against 12...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-0377

    authors: Batra S,Reynolds CP,Maurer BJ

    更新日期:2004-08-01 00:00:00

  • A comprehensive survey of Ras mutations in cancer.

    abstract::All mammalian cells express 3 closely related Ras proteins, termed H-Ras, K-Ras, and N-Ras, that promote oncogenesis when they are mutationally activated at codon 12, 13, or 61. Although there is a high degree of similarity among the isoforms, K-Ras mutations are far more frequently observed in cancer, and each isofor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-2612

    authors: Prior IA,Lewis PD,Mattos C

    更新日期:2012-05-15 00:00:00

  • Small-molecule intramimics of formin autoinhibition: a new strategy to target the cytoskeletal remodeling machinery in cancer cells.

    abstract::Although the cancer cell cytoskeleton is a clinically validated target, few new strategies have emerged for selectively targeting cell division by modulating the cytoskeletal structure, particularly ways that could avoid the cardiotoxic and neurotoxic effects of current agents such as taxanes. We address this gap by d...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1593

    authors: Lash LL,Wallar BJ,Turner JD,Vroegop SM,Kilkuskie RE,Kitchen-Goosen SM,Xu HE,Alberts AS

    更新日期:2013-11-15 00:00:00

  • Sensitive radiochemical assay for inosine 5'-monophosphate dehydrogenase and determination of activity in murine tumor and tissue extracts.

    abstract::Crude tissue or tumor extracts either do not contain sufficient inosine 5'-monophosphate dehydrogenase (IMPD) activity to be measured spectrophotometrically, or interfering enzyme activities prevent the use of a more sensitive radiochemical assay. A modified assay system which incorporates alpha, beta-methylene adenos...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Proffitt RT,Pathak VK,Villacorte DG,Presant CA

    更新日期:1983-04-01 00:00:00

  • Turnover modulates the need for a cost of resistance in adaptive therapy.

    abstract::Adaptive therapy seeks to exploit intra-tumoral competition to avoid, or at least delay, the emergence of therapy resistance in cancer. Motivated by promising results in prostate cancer, there is growing interest in extending this approach to other neoplasms. As such, it is urgent to understand the characteristics of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-20-0806

    authors: Strobl MAR,West J,Viossat Y,Damaghi M,Robertson-Tessi M,Brown JS,Gatenby RA,Maini PK,Anderson ARA

    更新日期:2020-11-10 00:00:00

  • Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridinylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage.

    abstract::The effect of combinations of the anthracycline aclarubicin and the topoisomerase II targeting drugs 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyra noside) (VP-16) and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) was investigated in a clonogenic assay. The cytotoxicity of VP-16 was almos...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Jensen PB,Sørensen BS,Demant EJ,Sehested M,Jensen PS,Vindeløv L,Hansen HH

    更新日期:1990-06-01 00:00:00

  • Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.

    abstract::Single-chain antigen-binding proteins, or sFvs, represent potentially unique molecules for targeted delivery of drugs, toxins, or radionuclides to a tumor site. In previous studies (Cancer Res., 51:6363-6371, 1991) using a human colon carcinoma xenograft model, it was demonstrated that the sFv has an extremely rapid p...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yokota T,Milenic DE,Whitlow M,Schlom J

    更新日期:1992-06-15 00:00:00

  • Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors.

    abstract::Thirty patients with cisplatin-refractory germ cell tumor were treated with high-dose carboplatin, etoposide, and cyclophosphamide and autologous bone marrow transplantation. The total dose of carboplatin was 1500 mg/m2, etoposide 1200 mg/m2, and cyclophosphamide was increased by increments from 60 to 150 mg/kg. Twent...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Motzer RJ,Gulati SC,Tong WP,Menendez-Botet C,Lyn P,Mazumdar M,Vlamis V,Lin S,Bosl GJ

    更新日期:1993-08-15 00:00:00

  • Retroviral insertional mutagenesis as a strategy for the identification of genes associated with cis-diamminedichloroplatinum(II) resistance.

    abstract::Expression of resistance to cis-diamminedichloroplatinum(II) (CDDP), one of the most effective chemotherapeutic drugs used to treat a variety of malignancies, remains a serious obstacle for improving cancer treatment. To study possible genetic mechanisms underlying the development of CDDP resistance, we have adopted t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lu SJ,Man S,Bani MR,Adachi D,Hawley RG,Kerbel RS,Ben-David Y

    更新日期:1995-03-01 00:00:00

  • Mimicry of bryostatin 1 induced phosphorylation patterns in HL-60 cells by high-phorbol ester concentrations.

    abstract::The bryostatins are a group of macrocyclic lactones isolated from the marine bryozoan Bugula neritina. Bryostatin 1, like the phorbol esters, activates protein kinase C; however, it partially inhibits the phorbol ester induced differentiation of the human promyelocytic leukemic cell line HL-60. We compared the phospho...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Warren BS,Kamano Y,Pettit GR,Blumberg PM

    更新日期:1988-11-01 00:00:00

  • In vivo administration of MKT-077 causes partial yet reversible impairment of mitochondrial function.

    abstract::The effects of in vivo administration of a pharmacologically toxic dose of the lipophilic cationic compound, MKT-077, were investigated in selected vital organs of the rat. MKT-077 (15 mg/kg body weight), administered by bolus i.v. injection every day for 5 days, did not detectably influence rat heart and kidney mitoc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Weisberg EL,Koya K,Modica-Napolitano J,Li Y,Chen LB

    更新日期:1996-02-01 00:00:00

  • A prospective study of hemoglobin A1c concentrations and risk of breast cancer in women.

    abstract::Impaired glucose metabolism and hyperinsulinemia have been hypothesized to increase breast cancer risk. However, findings from observational studies relating blood concentrations of hyperinsulinemia markers to breast cancer risk have been inconsistent. We prospectively evaluated whether hemoglobin A1c (HbA1c) concentr...

    journal_title:Cancer research

    pub_type: 杂志文章,随机对照试验

    doi:10.1158/0008-5472.CAN-05-3922

    authors: Lin J,Ridker PM,Rifai N,Lee IM,Manson JE,Buring JE,Zhang SM

    更新日期:2006-03-01 00:00:00

  • Stereoselective formation of in vitro nucleic acid adducts by 2,3-epoxy-4-hydroxynonanal.

    abstract::This paper describes the reactions of purine nucleosides and nucleic acids with 2,3-epoxy-4-hydroxynonanal. 2,3-Epoxy-4-hydroxynonanal was produced with tert-butyl hydroperoxide by epoxidation of trans-4-hydroxy-2-nonenal, a lipid peroxidation product. The epoxy aldehyde exists as a pair of diastereomers, I and II. Be...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sodum RS,Chung FL

    更新日期:1991-01-01 00:00:00

  • Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion.

    abstract::Pharmacokinetic studies of 5-fluorouracil (5-FUra) were performed on 18 patients divided into three groups: seven patients were given 5-FUra i.v. by rapid injection; five patients received the drug p.o.; and six patients were treated by continuous i.v. infusion for 96 hr. The results showed rapid i.v. injection to be ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fraile RJ,Baker LH,Buroker TR,Horwitz J,Vaitkevicius VK

    更新日期:1980-07-01 00:00:00

  • Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell-Mediated Immunotherapy.

    abstract::T-cell infiltration of solid tumors is associated with improved prognosis and favorable responses to immunotherapy. Mechanisms that enable tumor infiltration of CD8+ T cells have not been defined, nor have drugs that assist this process been discovered. Here we address these issues with a focus on VE-cadherin, a major...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-3129

    authors: Zhao Y,Ting KK,Li J,Cogger VC,Chen J,Johansson-Percival A,Ngiow SF,Holst J,Grau G,Goel S,Muller T,Dejana E,McCaughan G,Smyth MJ,Ganss R,Vadas MA,Gamble JR

    更新日期:2017-08-15 00:00:00

  • TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.

    abstract::Translocations fusing the strong androgen-responsive gene, TMPRSS2, with ERG or other oncogenic ETS factors may facilitate prostate cancer development. Here, we studied 18 advanced prostate cancers for ETS factor alterations, using reverse transcription-PCR and DNA and RNA array technologies, and identified putative E...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-1986

    authors: Iljin K,Wolf M,Edgren H,Gupta S,Kilpinen S,Skotheim RI,Peltola M,Smit F,Verhaegh G,Schalken J,Nees M,Kallioniemi O

    更新日期:2006-11-01 00:00:00

  • Human Pluripotent Stem Cell-Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis.

    abstract::Lymphangioleiomyomatosis (LAM) is a progressive destructive neoplasm of the lung associated with inactivating mutations in the TSC1 or TSC2 tumor suppressor genes. Cell or animal models that accurately reflect the pathology of LAM have been challenging to develop. Here, we generated a robust human cell model of LAM by...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-0925

    authors: Julian LM,Delaney SP,Wang Y,Goldberg AA,Doré C,Yockell-Lelièvre J,Tam RY,Giannikou K,McMurray F,Shoichet MS,Harper ME,Henske EP,Kwiatkowski DJ,Darling TN,Moss J,Kristof AS,Stanford WL

    更新日期:2017-10-15 00:00:00

  • Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer.

    abstract::Karyotypic and molecular genetic evidence has indicated that deletion or rearrangement of both chromosomes 3 and 13 may be important in the pathology of human small cell lung cancer (SCLC). The retinoblastoma susceptibility gene, RB, on chromosome 13 band q14, has previously been shown to be altered in SCLC [J. W. Har...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hensel CH,Hsieh CL,Gazdar AF,Johnson BE,Sakaguchi AY,Naylor SL,Lee WH,Lee EY

    更新日期:1990-05-15 00:00:00

  • The diet, nutrition, and cancer program of the NCI National Cancer Program.

    abstract::In November 1974, in response to a mandate in the revised National Cancer Act of 1974, a plan was introduced for the formation of a Diet, Nutrition, and Cancer Program. Dr. Frank J. Rauscher, Director of the National Cancer Institute, selected a group of scientists who defined the goals of the program and recommended ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gori GB

    更新日期:1975-11-01 00:00:00